BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38355020)

  • 1. Predicting exacerbations in COPD in the Danish general population.
    Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
    Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
    Ferrera MC; Lopez CL; Murray S; Jain RG; Labaki WW; Make BJ; Han MK
    Ann Am Thorac Soc; 2024 Mar; 21(3):421-427. PubMed ID: 37796613
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of exacerbations of asthma and COPD during one year in primary care.
    Al-ani S; Spigt M; Hofset P; Melbye H
    Fam Pract; 2013 Dec; 30(6):621-8. PubMed ID: 24115012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
    Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population.
    Marott JL; Çolak Y; Ingebrigtsen TS; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2022 Feb; 192():106725. PubMed ID: 34972025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Lange P; Nordestgaard BG
    Int J Epidemiol; 2016 Oct; 45(5):1551-1559. PubMed ID: 27118560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition.
    Ingebrigtsen TS; Marott JL; Lange P; Hallas J; Nordestgaard BG; Vestbo J
    Respir Med; 2015 Dec; 109(12):1562-8. PubMed ID: 26560643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
    Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CAPTURE to Identify Individuals Who May or May Not Require Treatment for Chronic Obstructive Pulmonary Disease.
    Li Y; Wen F; Ma Q; Chen R; Sun Y; Liu T; Gu C; Hu S; Song J; Compton C; Zheng J; Zhong N; Jones P
    Am J Respir Crit Care Med; 2023 Aug; 208(4):435-441. PubMed ID: 37315325
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.
    Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JWH; Sadatsafavi M; Sin DD; Carter V; Price DB
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1909-1918. PubMed ID: 32821093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 is a Strong Predictor of the Frequency of COPD Exacerbation Within 1 Year.
    Huang H; Huang X; Zeng K; Deng F; Lin C; Huang W
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2945-2951. PubMed ID: 34737559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.